Registering for more than one person? A TMA login is required for each person you register. Need help? Contact the TMA Knowledge Center at (800) 880-7955.
You must select a location to proceed.
Yes
No
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
This program is eligible to count towards federal and/or state mandated trainings.*
The Consolidated Appropriations Act of 2023 removed the “X-wavier” requirement for physicians to be able to prescribe buprenorphine. Could easing this restriction help wean the opioid-dependent population? Perhaps, but many physicians are not comfortable prescribing buprenorphine. Play this webinar to learn more.
Best Bits
Debunking common myths and misconceptions
Advantages and disadvantages of using buprenorphine
Best practices
Learning Objectives
Review common myths and misconceptions about buprenorphine;
Identify advantages and disadvantages of buprenorphine compared with full-agonist opioids;
Compare complex persistent opioid dependence with opioid use disorder;
Review recent recommendations for use of buprenorphine in chronic pain;
Identify options for rotating patients to buprenorphine from full-agonist opioids; and
Review the use of buprenorphine for treatment of opioid use disorders.
ACGME/ABMS Competencies This program addresses the following desirable physician attributes: provide patient-center care, interpersonal and communication skills, professionalism, systems-based practice, and roles/responsibilities.
Meeting Mandated CME Requirements This program is eligible to count towards: (i) the eight hours of training on treatment and management of patients with opioid or other substance use disorders required for all U.S. Drug Enforcement Administration-registered practitioners, and (ii) the two hours of CME in the study of pain management and the prescribing and monitoring of controlled substances required by the Texas Medical Board.
This program will address the specified topics of:
Best practices, alternative treatment options, and multimodal approaches to pain management that may include physical therapy, psychotherapy, and other treatments;
Safe and effective pain management related to the prescription of opioids and other controlled substances, including education regarding:
Standards of care;
Identification of drug-seeking behavior in patients; and
Effectively communicating with patients about the prescription of an opioid or other controlled substances; and
Prescribing and monitoring of controlled substances.
Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
Return Policy No refunds or exchanges will be processed for this program.
0.75 AMA PRA Category 1 Credits™ (Enduring) The Texas Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Medical Association designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
On select courses, the Texas Medical Association requires physician to complete 70-percent of the test questions correctly to receive credit for this course.
0.75 ETHICS This course has been designated for 0.75 credit(s) of education in medical ethics and/or professional responsibility.
0.75 Opioid This program is eligible to count towards the two hours of CME in the study of pain management and the prescribing and monitoring of controlled substances required by the Texas Medical Board. See the program description for the specific topics identified by the TMB that this program addresses. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
0.75 DEA SUD The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. This program is eligible to count towards the training requirement. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
Customers Who Bought This Item Also Bought
(On Demand Webinar) Multimodal Opioid-Sparing Strategies for Acute Pain Management
(On Demand Webinar) Amphetamines, the Next Epidemic: What History Has Not Taught Us
(On Demand Webinar) Addiction in Chronic Pain Patients: How to Know and What to Do
(On Demand Webinar) Red Flag Behaviors in Pain Management
(On Demand Webinar) Interpretation of Urine Drug Tests in Pain Management
(On Demand Webinar) Screening, Brief Intervention, and Referral to Treatment of Substance Use Disorders (SBIRT)
(CME to Go/Podcast) Opioid Stewardship
(On Demand Webinar) Healthy Conversations: Engaging with Your Patient about Substance Use Disorders
(On Demand Webinar) Shades of Grey
(On Demand Webinar) Management of Chronic Pain Patients with Substance Use Disorders
(On Demand Webinar) Change in Approach to Opioids
(On Demand Webinar) Meeting TMB Education Requirements for Opioid Prescribing
Adding Registration, Please wait...
